Ventas/$VTR
1D1W1MYTD1Y5YMAX
Capital at risk
About Ventas
Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.
- Ticker
- $VTR
- Sector
- Real Estate
- Primary listing
- NYSE
- Employees
- 542
- Headquarters
- Chicago, United States
- Website
- www.ventasreit.com
Ventas Metrics
BasicAdvanced
$45B
158.28
$0.55
0.73
$2.00
2.40%
Price and volume
Market cap
$45B
Beta
0.73
52-week high
$101.60
52-week low
$66.93
Average daily volume
3.5M
Dividend rate
$2.00
Financial strength
Current ratio
0.295
Quick ratio
0.133
Long term debt to equity
0.801
Total debt to equity
0.849
Dividend payout ratio (TTM)
353.06%
Interest coverage (TTM)
1.54%
Profitability
EBITDA (TTM)
2,380.86
Gross margin (TTM)
39.97%
Net profit margin (TTM)
4.09%
Operating margin (TTM)
15.17%
Effective tax rate (TTM)
-21.89%
Revenue per employee (TTM)
$11,840,000
Management effectiveness
Return on assets (TTM)
2.16%
Return on equity (TTM)
2.01%
Valuation
Price to earnings (TTM)
158.282
Price to revenue (TTM)
6.403
Price to book
3.04
Price to tangible book (TTM)
3.27
Price to free cash flow (TTM)
29.425
Free cash flow yield (TTM)
3.40%
Free cash flow per share (TTM)
2.951
Dividend yield (TTM)
2.30%
Forward dividend yield
2.40%
Growth
Revenue change (TTM)
21.68%
Earnings per share change (TTM)
27.46%
3-year revenue growth (CAGR)
14.68%
10-year revenue growth (CAGR)
6.66%
3-year earnings per share growth (CAGR)
42.34%
10-year earnings per share growth (CAGR)
-8.27%
3-year dividend per share growth (CAGR)
3.57%
10-year dividend per share growth (CAGR)
-10.53%
What the Analysts think about Ventas
Analyst ratings (Buy, Hold, Sell) for Ventas stock.
Analyst projections of the future price of Ventas stock.
Bulls say / Bears say
Ventas’ core senior-housing operating portfolio is accelerating: second-quarter same-store cash NOI rose 16% year over year, U.S. SHOP NOI increased 18%, occupancy improved 300 basis points, and normalized FFO per share increased 9%. (SEC earnings release)
The company is positioned to benefit from favorable senior-housing supply and demand dynamics. Management cited baby boomers reaching age 80 and historically low new supply, while raising full-year 2026 normalized FFO guidance to $3.85–$3.90 per share. (SEC earnings release)
Balance-sheet flexibility has improved despite the investment program: net debt to further adjusted EBITDA declined to 4.7x at June 30, and Ventas reported $4.9 billion of liquidity. (SEC earnings release)
Ventas’ rapid acquisition pace is increasing dependence on successful integration and lease-up execution: it completed $3.4 billion of senior-housing investments through June and raised its 2026 target to $4.5 billion. Management also flags acquisition, manager/tenant, leverage and asset-underperformance risks in its latest filing. (SEC filing)
Funding this expansion is materially equity-dependent: Ventas settled 31.4 million shares through June for $2.6 billion and had another $1.6 billion of unsettled equity forwards, creating potential dilution for existing shareholders. (SEC earnings release)
The shares may offer limited valuation cushion after their strong run: Bloomberg reported VTR at $90.27 on September 4, 2026, which is approximately 23.3 times Ventas’ midpoint 2026 normalized FFO guidance of $3.88 per share. (Bloomberg Línea; SEC earnings release)
Data summarised monthly by Lightyear AI. Last updated on 8 Sept 2026.
Ventas Financial Performance
Revenues and expenses
Ventas Earnings Performance
Company profitability
Upcoming events
Ventas News
AllArticlesVideos
Funds containing Ventas
AllEURGBPUSD
Fund name | Fund size | $VTR weighting |
|---|---|---|
VanEck Global Real Estate€TRET | €255M | 3.30% |
VanEck Global Real Estate£TREG | £222M | 3.30% |
iShares Developed Markets Property Yield$IDWP | $1.2B | 2.64% |
iShares Developed Markets Property Yield£IWDP | £859M | 2.64% |
iShares Ageing Population€AGED | €822M | 0.51% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.